天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

ChemicalBook Chinese Germany Japanese Korean

武漢敬康恩生物醫(yī)藥科技有限公司 Company Information
Company Name:    Wuhan Jingkangen Biomedical Technology Co., Ltd
Tel:    13720134139 +86 -0-15871494362
Email:    orders@jknbiochem.com
Nationality:    China
WebSite:    www.jknbiochem.com
Product List:    5821
6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59
Product List
Ulocuplumab 1375830-34-4
Bococizumab 1407495-02-6
Sofituzumab Vedotin 1418200-58-4
Dapirolizumab Pegol 1416147-64-2
Ralpancizumab 1407495-04-8
Tosatoxumab 1374419-41-6
Fletikumab 1357158-22-5
Enfortumab Vedotin 1346452-25-2
Anetumab Ravtansine 1375258-01-7
Guselkumab 1350289-85-8
Vantictumab 1345009-45-1
Anifrolumab 1326232-46-5
Tarextumab 1359940-55-8
Codrituzumab 1365267-33-9
Lifastuzumab Vedotin 1401812-88-1
Margetuximab 1350624-75-7
Tovetumab 1243266-04-7
Coltuximab Ravtansine 1269764-99-9
Bimekizumab 1418205-77-2
Denintuzumab Mafodotin 1399672-02-6
Varlilumab 1393344-72-3
Emibetuzumab 1365287-97-3
Brontictuzumab 1447814-75-6
Lulizumab Pegol 1421830-13-8
Abrilumab 1342290-43-0
Pasotuxizumab 1442657-12-6
Ontuxizumab 946415-62-9
Begelomab 1403744-56-8
Vanucizumab 1448221-05-3
Otlertuzumab 1372645-37-8
Abituzumab 1105038-73-0
Lumretuzumab 1448327-63-6
Emactuzumab 1448221-67-7
Vandortuzumab Vedotin 1471985-92-8
Evinacumab 1446419-85-7
Atezolizumab 1380723-44-3
Vobarilizumab 1628814-88-9
Amivantamab 2171511-58-1
Durvalumab 1428935-60-7
Scriptaid 287383-59-9
Tazemetostat (EPZ-6438) 1403254-99-8
HLCL-61 1158279-20-9
LMK-235 1418033-25-6
GW0742 317318-84-6
Aducanumab 1384260-65-4
Moclobemide (Ro 111163) 71320-77-9
PHA-767491(HCl) 845714-00-3
Vidofludimus;4SC-101 717824-30-1
Ganetespib 888216-25-9
AG 490 133550-30-8
TGX-221 663619-89-4
Oprozomib;ONX-0912 935888-69-0
BLU-9931 1538604-68-0
WP 1066 857064-38-1
PD 123319 ditrifluoroacetate 136676-91-0
SKF38393 HCl 62717-42-4
CID 755673 521937-07-5
A66 1166227-08-2
Go 6983 133053-19-7
SH-4-54 1456632-40-8
GSK 429286A 864082-47-3
KC7F2 927822-86-4
AZD9496 1639042-08-2
SB 366791 472981-92-3
Stattic 19983-44-9
Daprodustat;GSK1278863 960539-70-2
GW2580 870483-87-7
Apoptozole 1054543-47-3
VR23 1624602-30-7
Reversine 656820-32-5
BAY-57-1293;Pritelivir 348086-71-5
ON123300 1357470-29-1
HMN-214 173529-46-9
SW-033291 459147-39-8
APS-2-79 2002381-31-7
CC122 1015474-32-4
FPS-ZM1 945714-67-0
Kartogenin 4727-31-5
SB 742457 607742-69-8
Lenzilumab 1229575-09-0
Firivumab 1443004-15-6
Imalumab 1430205-07-4
Avelumab 1537032-82-8
Lokivetmab 1533403-95-0
Lacutamab 2187368-16-5
Research Grade Tafasitamab 1422527-84-1
Research Grade Obexelimab 1690307-05-1
Remtolumab 1791410-27-9
Vitamin K2 (Mk7) 2124-57-4
Idarucizumab 1362509-93-0
Eldelumab 946414-98-8
dinutuximab 1363687-32-4
mu-conotoxin 936616-33-0
BMS-986165 1609392-27-9
semaglutide 99291-20-0
Tirzepatide 2023788-19-2
3-Piperidinecarboxamide, N-(4,6-difluoro-2-benzothiazolyl)-1-[2-(dimethylamino)ethyl]- 2747162-85-0
UCB-9260 1515888-53-5
BLU-945 2660250-10-0
Sparsentan 254740-64-2
6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59
Copyright 2007©  ChemicalBook. All rights reserved.